Verition Fund Management LLC - EUCRATES BIOMEDICAL ACQU COR ownership

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$4,115,191
+3.7%
397,6030.0%0.06%
-8.1%
Q4 2022$3,968,078
-0.5%
397,603
-50.0%
0.06%
+37.8%
Q3 2022$3,987,984
+0.8%
795,206
+100.0%
0.04%
-42.3%
Q2 2022$3,956,000
+0.7%
397,6030.0%0.08%
+66.0%
Q1 2022$3,928,000
-1.0%
397,6030.0%0.05%
+62.1%
Q4 2021$3,968,000
-0.2%
397,6030.0%0.03%
-14.7%
Q3 2021$3,976,000
-1.9%
397,603
-0.0%
0.03%
-8.1%
Q2 2021$4,052,000
-0.1%
397,6920.0%0.04%
-19.6%
Q1 2021$4,056,000397,6920.05%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,264,0001.59%
Endurant Capital Management LP 195,000$2,079,0000.75%
CVI Holdings, LLC 355,000$3,784,0000.71%
Wealthspring Capital LLC 129,880$1,385,0000.69%
Sio Capital Management, LLC 300,000$3,198,0000.66%
Monashee Investment Management LLC 300,000$3,198,0000.42%
Sage Mountain Advisors LLC 95,970$1,023,0000.34%
683 Capital Management, LLC 600,000$6,396,0000.30%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 200,000$2,138,0000.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,132,0000.23%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders